Stefan Erb
Impact in
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- Clostridium difficile and Clostridium perfringens research
- HIV/AIDS Research and Interventions
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 5
- Clostridium difficile and Clostridium perfringens research 4
- Antimicrobial Resistance in Staphylococcus 3
- HIV/AIDS Research and Interventions 3
-
- Microscopic Colitis 2
- Co-authors
- Andreas F. Widmer (10 shared papers)Manuel Battegay (10 shared papers)Reno Frei (7 shared papers)Luigia Elzi (5 shared papers)Marc Dangel (4 shared papers)Sarah Tschudin‐Sutter (6 shared papers)Hansjakob Furrer (4 shared papers)Enos Bernasconi (3 shared papers)
- Journals
- PLoS ONE (3 papers)Swiss Medical Weekly (3 papers)Clinical Infectious Diseases (3 papers)Infection Control and Hospital Epidemiology (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- SwitzerlandTanzaniaSpain
In The Last Decade
Stefan Erb
24 papers receiving 521 citations
Peers
Comparison fields: 5 of 89
- Infectious Diseases 230
- Virology 44
- Molecular Medicine 26
- Applied Microbiology and Biotechnology 9
- Epidemiology 128
Countries citing papers authored by Stefan Erb
This map shows the geographic impact of Stefan Erb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Erb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Erb more than expected).
Fields of papers citing papers by Stefan Erb
This network shows the impact of papers produced by Stefan Erb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Erb. The network helps show where Stefan Erb may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Erb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 87 | |
| 2 | 2014 | 64 | |
| 3 | 2015 | 36 | |
| 4 | 2016 | 29 | |
| 5 | 2017 | 28 | |
| 6 | 2012 | 28 | |
| 7 | 2018 | 25 | |
| 8 | 2016 | 25 | |
| 9 | 2017 | 25 | |
| 10 | 2016 | 23 | |
| 11 | 2018 | 23 | |
| 12 | 2018 | 19 | |
| 13 | 2000 | 19 | |
| 14 | 2018 | 16 | |
| 15 | 2016 | 15 | |
| 16 | 2014 | 14 | |
| 17 | 2017 | 13 | |
| 18 | 2017 | 13 | |
| 19 | 2018 | 11 | |
| 20 | 2017 | 9 |
About Stefan Erb
Stefan Erb is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Virology and Molecular Medicine, having authored 24 papers that have together received 541 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Streptococcal Infections and Treatments (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), HIV/AIDS Research and Interventions (3 papers), Biosimilars and Bioanalytical Methods (2 papers), Central Venous Catheters and Hemodialysis (2 papers) and Microscopic Colitis (2 papers). The work is most often cited by research in Infectious Diseases (230 citations), Virology (44 citations), Molecular Medicine (26 citations), Applied Microbiology and Biotechnology (9 citations) and Epidemiology (128 citations). Stefan Erb has collaborated with scholars based in Switzerland, Tanzania and Spain. Frequent co-authors include Andreas F. Widmer, Manuel Battegay, Reno Frei, Luigia Elzi, Marc Dangel, Sarah Tschudin‐Sutter, Hansjakob Furrer, Enos Bernasconi, Matthias Cavassini and Anne Stranden. Their work appears in journals such as PLoS ONE, Swiss Medical Weekly, Clinical Infectious Diseases, Infection Control and Hospital Epidemiology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.